On June 27, 2025, Unity Biotechnology, Inc. was notified by Nasdaq that it would be delisted due to failing to meet listing requirements, including a lack of an operating business, and announced its board's resignation amid plans for dissolution. The company will not appeal the delisting decision and seeks stockholder approval for dissolution at a special meeting.